SCHEMBL6408692

SCHEMBL6408692

Cc1ccc(-n2c(SCC(=O)c3ccccc3)nnc2-c2ccncc2)cc1

nearest known ligand 0.79

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 5/20 0.79
LMNA P02545 4/20 0.72
ALDH1A1 P00352 4/20 0.70
L3MBTL1 Q9Y468 1/20 0.70
RXFP1 Q9HBX9 1/20 0.67
POLB P06746 3/20 0.67
CDC25A P30304 2/20 0.66
CDC25B P30305 2/20 0.66
CYP3A4 P08684 1/20 0.66
CYP2D6 P10635 1/20 0.66
CYP2C9 P11712 1/20 0.66
CYP2C19 P33261 1/20 0.66
HSD17B10 Q99714 2/20 0.66
ALOX15 P16050 1/20 0.66
TSHR P16473 1/20 0.66
NPSR1 Q6W5P4 1/20 0.64
HPGD P15428 1/20 0.64
RECQL P46063 1/20 0.64
ALPG P10696 1/20 0.64
HTT P42858 2/20 0.62

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6209335 0.93 LMNA (0.77) MAPTLMNAALDH1A1L3MBTL1RXFP1
SCHEMBL6192068 0.91 MAPT (0.91) MAPTLMNAALDH1A1L3MBTL1RXFP1
SCHEMBL6274937 0.88 MAPT (0.77) MAPTLMNAALDH1A1L3MBTL1RXFP1
SCHEMBL6192401 0.87 ALPG (0.74) MAPTLMNAALDH1A1POLBCDC25A
SCHEMBL6210228 0.86 MAPT (0.71) MAPTLMNAALDH1A1L3MBTL1RXFP1
SCHEMBL6212432 0.86 LMNA (0.80) MAPTLMNAALDH1A1L3MBTL1RXFP1
SCHEMBL6193193 0.85 CDC25A (0.74) MAPTLMNAALDH1A1L3MBTL1RXFP1
SCHEMBL6839263 0.83 MAPT (0.85) MAPTLMNARXFP1POLBCDC25A
SCHEMBL6192012 0.83 ALPG (0.69) MAPTLMNAALDH1A1RXFP1POLB
SCHEMBL6210137 0.83 POLB (0.89) MAPTLMNAALDH1A1L3MBTL1RXFP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20050288347-A1 Certain triazole-based compounds, compositions, and uses thereof AGRIUS GROUP, LLC. 2005-12-29 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050288347-A1 Certain triazole-based compounds, compositions, and uses thereof ABCG2, ATP5ME, DNTT MAPT 2111/4885LMNA 4116/4885ALDH1A1 720/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.